Effector memory T cell (T_EM (or Tem))

Effector memory T cells are a functional subset of memory T lymphocytes distinguished from naive and central memory T cells by their ability to rapidly exert effector functions (such as cytokine production or cytotoxicity) upon re-exposure to specific antigens, without requiring further differentiation. T_EM cells typically lack lymph node homing receptors like CCR7 and CD62L and are found in peripheral tissues, ready to respond quickly to previously encountered pathogens[2][4][5][6]. They play pivotal roles in protective immunity against infections and cancer by providing swift secondary immune responses. The term "activated effector-memory T cell" refers to T_EM cells that have recently encountered antigen and are functionally active, but this is a cell population/state, not a single druggable molecular target[3][4][5]. Effector memory T cells can be further classified as CD4+ or CD8+ based on co-receptor expression, but as a whole, they are not themselves a molecular target such as a receptor, enzyme, or transporter[2][7]. Therapeutic approaches such as vaccines and adoptive T cell therapies often aim to boost or utilize effector memory T cells for durable immune protection[5][6]. Drug interactions and mechanisms typically act upstream (e.g., checkpoint blockade) or involve depleting/expanding T cell compartments, but do not target T_EM cells as a molecular entity[4][5].

Other names

Effector-memory T cellT_EM cellEffector memory CD4+ T cellEffector memory CD8+ T cell